Genetic test aims to get vets on statins and cut heart risk
NCT ID NCT06568601
First seen Jun 25, 2026 · Last updated Jun 25, 2026
Summary
This study tests whether genetic testing can help veterans at high risk for heart disease start and stick with statin medications. About 410 veterans aged 40-75 with diabetes or heart disease who are not currently taking statins will receive either a genetic report on their statin response and heart risk, or a standard risk report. The goal is to see if personalized genetic information improves cholesterol levels over 15 months.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DIABETES MELLITUS are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Durham VA Medical Center, Durham, NC
NOT_YET_RECRUITINGDurham, North Carolina, 27705-3875, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
-
Richard L. Roudebush VA Medical Center, Indianapolis, IN
RECRUITINGIndianapolis, Indiana, 46202-2884, United States
Contact Email: •••••@•••••
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
pharmacogenetic and polygenic risk testing
What this could lead to
If successful, this approach could help more veterans lower their cholesterol and reduce heart disease risk by personalizing statin therapy.
What could go wrong
This is a relatively small, early-stage study (410 participants) and focuses on behavior change, not a new drug. Results may not apply to non-veterans or those already on statins.
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.